SavedAdd your journal

Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2016 / Cilt: 22 - Sayı: 2

Screening for Syphilis During Pregnancy in Turkey

YUSUF AYTAÇ TOHMA
Hasan ENERGİN
Emel Ebru ÖZÇİMEN
Eser ÇOLAK
Pages
72–74
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the prevalence of syphilis, each country should determine its own syphilisantenatal screening policies

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: To assess the prevalence of syphilis among patients at a tertiary referral center in Turkeyand determine the need for antenatal syphilis screening based on the results.STUDY DESIGN: A retrospective cohort study based on patient data obtained from a tertiary referralcenter in Turkey.
📊
Key Findings & Data:Treponema pallidum hemagglutination assay (TPHA) was used to confirm positive screening results for syphilis.RESULTS: Patients' mean age was 27.4 years.
💡
Conclusion & Impact:According to the prevalence of syphilis, each country should determine its own syphilisantenatal screening policies
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: To assess the prevalence of syphilis among patients at a tertiary referral center in Turkeyand determine the need for antenatal syphilis screening based on the results.STUDY DESIGN: A retrospective cohort study based on patient data obtained from a tertiary referralcenter in Turkey. Serological syphilis screening using the Venereal Disease Research Laboratory(VDRL) was performed on all pregnant women as a part of routine antenatal care at their first hospitalvisit during pregnancy. Treponema pallidum hemagglutination assay (TPHA) was used to confirm positive screening results for syphilis.RESULTS: Patients' mean age was 27.4 years. The incidence of positive syphilis serology was 0.013%(one patient), which was supported by a positive confirmatory test (0.013%). The TPHA-positive pregnant woman diagnosed with syphilis was treated with benzathine penicillin, and she gave birth to normal infants without any signs of congenital syphilis.CONCLUSION: Syphilis prevalence should be determined in each developing country with populationbased studies. According to the prevalence of syphilis, each country should determine its own syphilisantenatal screening policies

🔖

Cite This Article

TOHMA, Y. A., ENERGİN, H., ÖZÇİMEN, E. E., ÇOLAK, E. (2016). Screening for Syphilis During Pregnancy in Turkey. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 22 - Sayı: 2, 72–74. https://ajindex.com/articles/190624

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. World Health Organization. The global elimination of congenital syphilis: rationale and strategy for action. Geneva: World Health Organization 2008. Newman L. Kamb M. Hawkes S. Gomez G. Say L. Seuc, A. Broutet, N. Global estimates of syphilis in pregnancy and associated adverse outcomes: analysis of multina- tional antenatal surveillance data. PLoS Med 2013; 10(2):e1001396 Bittencourt AL, Garcia AG. Pathogenesis and pathology of hematogenous infections of the fetus and newborn. Pediatr Pathol Mol Med 2002; 21:353-99. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines MMWR 2006; 55:1-94.
  2. Yang LG, Tucker JD, Liu FY, Ren XQ, Hong X, Wang C, et al. Syphilis screening among 27,150 pregnant women in south Chinese rural areas using point-of-care tests. PLoS ONE 2013;8(8):e72149. Peeling RW, Ye H. Diagnostic tools for preventing and managing maternal and congenital syphilis: an overview. Bull World Health Organ 2014;82:439-46.
  3. Domingues RM, Szwarcwald CL, Souza PRB, Leal Mdo C. Prevalence of syphilis in pregnancy and prenatal syphilis testing in Brazil: birth in Brazil study. Rev Saude Publica 2014;48:766-74.
  4. Akturk AS, Bilen N, Demirsoy EO, Kiran R. The in- creased rates of syphilis in Turkey in the beginning of the third millennium. J Eur Acad Dermatol Venereol 2009;23: 1209-10.
  5. Oner S YG, Şaşmaz CT, Kurt AÖ, Buğdaycı R. Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey. Turk J Med Sci 2011;41:335-41. Ensari T. Kirbas A. Özgü Erdinc AS. Gökay Saygan S. Erkaya S. Uygur D. et al. An eight-year retrospective analysis of antenatal screening results for syphilis: is it still cost effective?. J Infect Dev Ctries 2015;9(9):1011-5. Demirel Y. Duran B. Toktamis A. Erden O. Cetin M. Seroprevalence of syphilis, hepatitis B and C, and human immunodeficiency virus infections among women. Saudi Med J 2004;25:2037-8. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. Geneva: World Health Organization 2011.
  6. Blencowe H, Cousens S, Kamb M, Berman S, Lawn JE. Lives Saved Tool supplement detection and treatment of syphilis in pregnancy to reduce syphilis related stillbirths and neonatal mortality. BMC Public Health 2011;11 (Suppl 3):S9. Hawkes S, Matin N, Broutet N, Low N. Effectiveness of interventions to improve screening for syphilis in preg- nancy: a systematic review and meta-analysis. Lancet Infect Dis 2011;11:684-91.
  7. Fonck K, Claeys P, Bashir F, Bway